However, the ability to signal downstream of the pre-BCR is selected against in Ph+ leukemias, and BCR-ABL1-mediated repression of pre-BCR-induced Ca2+ signaling has been described in Ph+ B-ALL patients, and in a mouse ALL model [14], [15], [83]. This evidence concerns the gene BCR and acute lymphoblastic leukemia.